| For: | Dai JJ, Liu YY, Zhang ZH. Changes in the etiology of liver cirrhosis and the corresponding management strategies. World J Hepatol 2024; 16(2): 146-151 [PMID: 38495283 DOI: 10.4254/wjh.v16.i2.146] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v16/i2/146.htm |
| Number | Citing Articles |
| 1 |
Bin Tang, Qifan Xiao, Mande Kang, Xin Yang, Yuqing Zhu. Baicalin improves metabolic dysfunction-related fatty liver disease in mice by regulating the AMPK/mTOR/SREBP-1 signaling axis. Journal of Radiation Research and Applied Sciences 2026; 19(4) doi: 10.1016/j.jrras.2026.102799
|
| 2 |
舒婷 陈. Research Progress of GLP-1 Receptor Agonists in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Clinical Personalized Medicine 2025; 4(03) doi: 10.12677/jcpm.2025.43402
|
| 3 |
Florian Weber, Katja Evert, Alexander Scheiter, Sophie von Sachsen-Coburg, Kirsten Utpatel, Christa Buechler. The Niemann–Pick C1 Protein of Patients with Hepatocellular Carcinoma Is Associated with Survival Time in Males and Tumor Size in Females. Biomedicines 2025; 13(7) doi: 10.3390/biomedicines13071707
|
| 4 |
T. E. Polunina. A multi-targeting approach to phytotherapy of liver diseases. Meditsinskiy sovet = Medical Council 2026; (8) doi: 10.21518/ms2026-162
|
| 5 |
Pranali A. Jadhav, Asha B. Thomas, Mohsin K. Pathan, Somdatta Y. Chaudhari, Ravindra D. Wavhale, Sohan S. Chitlange. Unlocking the therapeutic potential of unexplored phytocompounds as hepatoprotective agents through integration of network pharmacology and in-silico analysis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-92868-y
|